Insight Cost Of Revenue from 2010 to 2025
| IMDX Stock | 5.82 0.41 7.58% |
Cost Of Revenue | First Reported 2020-03-31 | Previous Quarter 168 K | Current Value 121 K | Quarterly Volatility 628.1 K |
Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 66.1 M, as well as many indicators such as Price To Sales Ratio of 15.71, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.
Insight | Cost Of Revenue | Build AI portfolio with Insight Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.